This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component(Empagliflozin and Metformin) in Healthy Adult Volunteers in Fast Condition.
Clinical trial NCT05823870 · COMPLETED
Trial details
- NCT number
- NCT05823870
- Sponsor
- Dong Wha Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-24
- Primary completion
- 2023-03-06
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.